Public list Pharma Startups (6570):
RedHill Biopharma (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is an Israeli pharmaceutical company focused primarily on acquisition and development of late clinical-stage new formulations of existing drugs.
Company (IPO / Went public)
21 Ha’arba’a St.
Tel Aviv, 6473921
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Therapy for inhibition of single-stranded rna virus replication||Oct 23, 2015||May 22, 2018||Patent|
|Composition and method for treating an autoimmune disease||Sep 19, 2012||Feb 27, 2018||Patent|
|Combination therapies for treating cancer||Oct 06, 2016||Dec 19, 2017||Patent|
|Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms||Mar 11, 2015||Jun 13, 2017||Patent|
|Antiemetic extended release solid dosage forms||Mar 14, 2014||May 02, 2017||Patent|